We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Berry Oncology Corporation, a member company of China's leading early cancer screening firm Berry Genomics, yesterday on its 4th anniversary, announced the completion of a US$99.15 million Series B1 financing round.
Berry Oncology Corporation, a member company of Berry Genomics, and Alibaba Health have signed a strategic agreement to jointly build a comprehensive cancer screening and prevention ecosystem based on a strategy that combines internet connectivity ...